Significance of Staphylococcus lugdunensis bacteremia:: Report of 28 cases and review of the literature

被引:78
|
作者
Zinkernagel, A. S. [1 ,2 ]
Zinkernagel, M. S. [3 ]
Elzi, M. V. [4 ]
Genoni, M. [3 ]
Gubler, J. [5 ]
Zbinden, R. [6 ]
Mueller, N. J. [1 ,2 ]
机构
[1] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Hosp Epidemiol, Dept Internal Med, CH-8091 Zurich, Switzerland
[3] Triemli Hosp Zurich, Div Heart Surg, Zurich, Switzerland
[4] Univ Bern, Inst Infect Dis, Bern, Switzerland
[5] Triemli Hosp Zurich, Div Infect Dis, Zurich, Switzerland
[6] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland
关键词
D O I
10.1007/s15010-008-7287-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Stophylococcus lugdunensis endocarditis has been associated with an aggressive course. The aim of this study was to determine factors associated with the development of endocarditis in patients with S. lugdunensis bacteremia. Methods: A retrospective analysis of all patients with S. lugdunensis bacteremia in three tertiary care centers in Switzerland was performed. Data regarding medical history, symptoms, and susceptibility of S. lugdunensis isolates were collected. Our results were reviewed in the context of the current literature. Results: A total of 28 patients with S. lugdunensis bacteremia were identified. Of the 13 patients with endocarditis, all were community acquired. Cardiac surgery was performed in 85% of these patients; mortality was 23%, reflecting the aggressive course of this disease. In contrast, in the 15 patients without endocarditis, no complications associated with S. lugdunensis bacteremia were observed. In 73%, a probable source was identified in the form of a venous catheter or other foreign device. Only three of these episodes were community acquired. No difference was observed in susceptibility of the S. lugdunensis isolates to penicillin, which was 77% in endocarditis isolates, and 87% in isolates of bacteremia without endocarditis, respectively. Conclusion: S. lugdunensis bacteremia is associated with endocarditis in up to 50% of patients. Every patient with community-acquired S. lugdunensis bacteremia should be carefully examined for signs of endocarditis. Once S. lugdunensis endocarditis is diagnosed, close monitoring is essential and surgical treatment should be considered early. In the nosocomial setting, endocarditis is far less frequent, and S. lugdunensis bacteremia is usually associated with a catheter or other foreign materials.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 50 条
  • [31] Neisseria macacae bacteremia: report of two cases with a literature review
    Yasumasa Yamamoto
    Norihiko Terada
    Tomoyo Sugiyama
    Hanako Kurai
    Kiyofumi Ohkusu
    [J]. BMC Infectious Diseases, 20
  • [32] ACHROMOBACTER XYLOSOXIDANS BACTEREMIA ACHROMOBACTER XYLOSOXIDANS BACTEREMIA: REPORT OF THREE CASES AND REVIEW OF THE LITERATURE
    Chien, Hou
    Hsin, Chu Yuan
    [J]. RESPIROLOGY, 2019, 24 : 125 - 125
  • [34] Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia
    Forsblom, Erik
    Hognas, Emma
    Syrjanen, Jaana
    Jarvinen, Asko
    [J]. PLOS ONE, 2021, 16 (10):
  • [35] Successful treatment of Staphylococcus lugdunensis endocarditis complicated by multiple emboli: A case report and review of the literature
    Koh, TW
    Brecker, SJD
    Layton, CA
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 55 (02) : 193 - 197
  • [36] A Frequently Overlooked Contaminant: A Case of Staphylococcus lugdunensis Bacteremia
    Hunter, Nicole
    Kusnik, Alexander
    Proia, Laurie
    [J]. JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2023, 13 (04):
  • [37] A case of Staphylococcus lugdunensis bacteremia complicated by reactive arthritis
    Gaut, Daria
    Muir, Kyle
    Pessegueiro, Antonio M.
    [J]. SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [38] Clinical experience with Staphylococcus lugdunensis bacteremia:: a retrospective analysis
    Ebright, JR
    Penugonda, N
    Brown, W
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 48 (01) : 17 - 21
  • [39] Staphylococcus lugdunensis bacteremia and endocarditis treated with cefazolin and rifampin
    Duhon, Bryson
    Dallas, Steven
    Velasquez, Sadie T.
    Hand, Elizabeth
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (13) : 1114 - 1118
  • [40] Beware of the coagulase negative, staphylococcus lugdunensis bacteremia - It is not a contaminant!
    Asnis, D
    Toronjadze, T
    Febles, T
    Abramovici, B
    Hsueh, J
    Dave, D
    Vela, A
    Panchenko, O
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S69 - S70